Special Announcements  |   October 2017
Journal-related Activities and Other Special Activities at the 2017 American Society of Anesthesiologists Meeting
Author Notes
  • From the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (M.J.A.); Departments of Anesthesiology and Biochemistry and Molecular Biophysics, Washington University in St. Louis, St. Louis, Missouri (E.D.K.); St. Louis Center for Clinical Pharmacology, Washington University in St. Louis and St. Louis College of Pharmacy, St. Louis, Missouri (E.D.K.); Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, Michigan (S.K.); Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Boston, Massachusetts (J.P.R.); Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio (D.I.S.); Outcomes Research Consortium, Cleveland, Ohio (D.I.S.).
  • Submitted for publication July 18, 2017. Accepted for publication July 18, 2017.
    Submitted for publication July 18, 2017. Accepted for publication July 18, 2017.×
Article Information
Special Announcements
Special Announcements   |   October 2017
Journal-related Activities and Other Special Activities at the 2017 American Society of Anesthesiologists Meeting
Anesthesiology 10 2017, Vol.127, 601-608. doi:10.1097/ALN.0000000000001832
Anesthesiology 10 2017, Vol.127, 601-608. doi:10.1097/ALN.0000000000001832
Sunday, October 22, 2017, 9:00 am to 12:00 pm, 206 A-B
The 2017 Journal Symposium titled “Frontiers in Opioid Pharmacotherapy” addresses the latest science on opioid pharmacology, use, and misuse. It will feature the following moderators and speakers.
Evan D. Kharasch, M.D., Ph.D., Editor-in-Chief, Anesthesiology, and Washington University in St. Louis, St. Louis, Missouri; and James P. Rathmell, M.D., Executive Editor, Anesthesiology, and Brigham and Women’s Hospital/Harvard Medical School, Boston, Massachusetts.
Opioids have been the mainstay of pain therapy for thousands of years. Recent decades have seen tidal shifts in the therapeutic application of opioids for acute, postoperative, chronic, neuropathic, and cancer pain as emphasis on adequate pain treatment has grown. Opioid-related problems, including addiction, diversion, and overdose, have also grown concurrently with increased clinical use of opioids. Changes in individual practice, group guidelines, and policy recommendations all aimed at stemming the tide of abuse and diversion have rapidly emerged. Concurrently, there have been recent giant leaps in understanding and application of opioid pharmacology. These discoveries have challenged and sometimes reversed decades of conventional wisdom in pharmacology. New concepts in opioid pharmacology have spawned major new efforts in drug discovery toward the development of opioids with greater clinical effectiveness and/or diminished side effects and are also changing the way clinicians use existing opioids. New opioids are advancing through clinical trials, with intended application for pain, itch, depression, and other therapeutic areas.
First Page Preview
First page PDF preview
First page PDF preview ×
View Large